From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal
Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the Company’s DLA portfolio Continued patient...
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused...
Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”), with gross proceeds from the...
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH),...
--Type A meeting with FDA expected late Q3 to define pathway to potential approval for Oral Sulopenem following July’s Complete...
-- Phase 1/2 ABILITY Study of MDNA11 in patients with advanced solid tumors remains on track for initiation in the...
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for...
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance therapeutics portfolio to drive future...
Longeveron to hold conference call today at 8:00 AM EDTMIAMI, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN)...
CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies...
-- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response in six-minute walk test (6MWT)...
Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021LONDON, Aug. 13, 2021 (GLOBE NEWSWIRE)...
OTTAWA, Aug. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today it...
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission CMC and Non-Clinical Sections Will...
In relation to the previously announced JSC AB CITY mandatory repurchase of JSC Olainfarm shares, Financial and Capital Market Commission has published the...
VANCOUVER, British Columbia, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABD), (Frankfurt: LD6, WKN:...
Company announcement, Inside Information, Helsinki, 13 August 2021 at 09:00 am (EEST) NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30...
Message from the CEO As is well known, IBT is conducting a large phase III study ("The Connection Study"), the...
Pixium Vision announces geographical expansion of PRIMAvera European pivotal study with opening of first UK clinical site at Moorfields Eye...
